I think the problem we have (which is a good problem, not a bad one) is that the exceptional value lies in the pipeline BOT have, which I'm not sure another party is prepared to pay for yet. Sofdra will be the cash cow that supports developing acne, AM, and rosacea through to approval and market. So if BOT are going to sell Sofdra alone, it'd have to be for +$2 to make it viable to progress everything else. Admittedly, that is only $2bUSD, which I think would be good value to BP for the planet's superior AH product and a global licence on it.
- Forums
- ASX - By Stock
- BOT
- Ann: Botanix to Present at Euroz Hartleys Conference
Ann: Botanix to Present at Euroz Hartleys Conference, page-94
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
-0.005(1.54%) |
Mkt cap ! $581.5M |
Open | High | Low | Value | Volume |
32.5¢ | 33.0¢ | 32.0¢ | $1.058M | 3.280M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 147750 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 632850 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 147750 | 0.320 |
22 | 742217 | 0.315 |
27 | 827188 | 0.310 |
11 | 272208 | 0.305 |
28 | 366102 | 0.300 |
Price($) | Vol. | No. |
---|---|---|
0.325 | 632850 | 6 |
0.330 | 90273 | 5 |
0.335 | 193342 | 5 |
0.340 | 408713 | 7 |
0.345 | 406365 | 7 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online